PICC Inserted by a Nurse-led Vascular Access Team in Poland

NCT ID: NCT06979128

Last Updated: 2025-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-05

Study Completion Date

2026-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Implantation of PICCs by a trained, dedicated nursing team can be effective and safe, and allows for intravenous therapy that requires medium- to long-term central venous access.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The insertion of Peripherally Inserted Central Catheters (PICCs) offers numerous advantages over direct puncture of central veins. Ultrasound-guided insertion of PICCs into the peripheral vein is characterized by the high efficiency and safety of the procedure as well as patient comfort, and is a safe alternative to centrally inserted central catheters (CICCs) associated with a lower risk of complications. The PICCs will be inserted into one of the veins of the arm (basilic, brachial, cephalic) under ultrasound guidance. Cannulation will be supervised by a physician. Prior to cannulation a local anesthetic drug will be applied to the site of the planned puncture. Each PICC cannulation set consists of an echogenic needle, a guidewire, an introducer, a catheter with a diameter of 4 or 5 Fr and a length of 50-60 cm, a adhesive sutureless fixation, a semi-permeable transparent dressing, a needleless connector and a sticker indicating the type of vascular access. During the procedure intracavitary ECG will be used to catheter tip navigation. After the procedure, a chest X-ray will be taken to document the correct position of the tip. Taking into account the experience of the researchers and the learning curve described in the literature, it is planned to perform 200 PICC insertion procedures during the study period (50 per operator).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vascular Access PICC Line Placement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients who requrie a PICC

All subjects patients who requrie a PICC

PICC placement

Intervention Type PROCEDURE

Patient scheduled for PICC placement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PICC placement

Patient scheduled for PICC placement

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18 years
* Intravenous therapy with solutions requiring central vein cannulation (irritant drugs, extreme pH \<5 and \>9, osmolarity \> 600 mOsm/l), e.g., chemotherapy, parenteral nutrition with osmolarity \>900 mOsm/l
* Difficult intravenous access with multiple blood collection
* Ability to consent to participate in the study
* Consent to participate in the study

Exclusion Criteria

* Presence of central venous catheter, such as. centrally inserted central catheter or totally implanted vascular device
* Indication of another type of vascular access device
* Lack of veins suitable for cannulation of the arm
* Infection, burns or other skin lesion on the upper extremities (involving the site of planned catheter insertion and attachment)
* Pregnancy (confirmed by history and review of medical records or confirmed by positive human chorionic gonadotropin (hCG) determination in urine or plasma)
* Lack of patient consent to participate in the study
* Lack of capacity to consent to participate in the study
* No physician present to supervise the procedure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Warsaw

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical University of Warsaw

Warsaw, , Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dr Maciej Latos

Role: CONTACT

48601292532

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dr Maciej Latos

Role: primary

48601292532

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KB/35/2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Microorganisms on Reusable Tourniquets
NCT06566495 ACTIVE_NOT_RECRUITING
Midlines and Thrombophlebitis
NCT03725293 COMPLETED NA